| Targeted reduction of advanced glycation improves renal function in obesity. | |
| | |
MedLine Citation:
|
PMID: 21412218 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Obesity is highly prevalent in Western populations and is considered a risk factor for the development of renal impairment. Interventions that reduce the tissue burden of advanced glycation end-products (AGEs) have shown promise in stemming the progression of chronic disease. Here we tested if treatments that lower tissue AGE burden in patients and mice would improve obesity-related renal dysfunction. Overweight and obese individuals (body mass index (BMI) 26-39 kg/m(2)) were recruited to a randomized, crossover clinical trial involving 2 weeks each on a low- and a high-AGE-containing diet. Renal function and an inflammatory profile (monocyte chemoattractant protein-1 (MCP-1) and macrophage migration inhibitory factor (MIF)) were improved following the low-AGE diet. Mechanisms of advanced glycation-related renal damage were investigated in a mouse model of obesity using the AGE-lowering pharmaceutical, alagebrium, and mice in which the receptor for AGE (RAGE) was deleted. Obesity, resulting from a diet high in both fat and AGE, caused renal impairment; however, treatment of the RAGE knockout mice with alagebrium improved urinary albumin excretion, creatinine clearance, the inflammatory profile, and renal oxidative stress. Alagebrium treatment, however, resulted in decreased weight gain and improved glycemic control compared with wild-type mice on a high-fat Western diet. Thus, targeted reduction of the advanced glycation pathway improved renal function in obesity.Kidney International advance online publication, 16 March 2011; doi:10.1038/ki.2011.57. |
| | |
Authors:
|
Brooke E Harcourt; Karly C Sourris; Melinda T Coughlan; Karen Z Walker; Sonia L Dougherty; Sofianos Andrikopoulos; Amy L Morley; Vicki Thallas-Bonke; Vibhasha Chand; Sally A Penfold; Maximilian P J de Courten; Merlin C Thomas; Bronwyn A Kingwell; Angelika Bierhaus; Mark E Cooper; Barbora de Courten; Josephine M Forbes |
Related Documents
:
|
3424028 - Nutrient intake and dietary supplementation in body-builders. 8564528 - Endotoxin induced production of interleukin-6 is enhanced by vitamin e deficiency and r... 9386258 - Diet and nutrition in primary care. from antioxidants to zinc. 4011558 - Interaction of dietary fat with levels of vitamins a and e in broiler chicks. 2340988 - Reproductive effects of diethylene glycol and diethylene glycol monoethyl ether in swis... 1780708 - An animal model to study the effects of diet on risk factors of calcium stone formation. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-16 |
Journal Detail:
|
Title: Kidney international Volume: - ISSN: 1523-1755 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0323470 Medline TA: Kidney Int Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1] Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia [2] Department of Immunology and Medicine, Monash University, Melbourne, Victoria, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cell biological and physicochemical aspects of arterial calcification.
Next Document: RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.